nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolpidem—Somnambulism—Varenicline—nicotine dependence	0.0245	0.0433	CcSEcCtD
Zolpidem—Restless legs syndrome—Varenicline—nicotine dependence	0.0172	0.0304	CcSEcCtD
Zolpidem—Anger—Varenicline—nicotine dependence	0.0138	0.0243	CcSEcCtD
Zolpidem—Abnormal behaviour—Varenicline—nicotine dependence	0.0132	0.0233	CcSEcCtD
Zolpidem—Varicose vein—Varenicline—nicotine dependence	0.0132	0.0233	CcSEcCtD
Zolpidem—GABRB2—GABA A receptor activation—GABRA4—nicotine dependence	0.0123	0.0282	CbGpPWpGaD
Zolpidem—Withdrawal symptom—Varenicline—nicotine dependence	0.012	0.0212	CcSEcCtD
Zolpidem—GABRA3—GABA A receptor activation—GABRA4—nicotine dependence	0.0117	0.0269	CbGpPWpGaD
Zolpidem—GABRA2—GABA A receptor activation—GABRA4—nicotine dependence	0.0115	0.0264	CbGpPWpGaD
Zolpidem—GABRB3—GABA A receptor activation—GABRA4—nicotine dependence	0.0114	0.0263	CbGpPWpGaD
Zolpidem—GABRG2—GABA A receptor activation—GABRA4—nicotine dependence	0.0112	0.0258	CbGpPWpGaD
Zolpidem—Depressed mood—Varenicline—nicotine dependence	0.011	0.0194	CcSEcCtD
Zolpidem—Drug withdrawal syndrome—Varenicline—nicotine dependence	0.01	0.0177	CcSEcCtD
Zolpidem—GABRA1—GABA A receptor activation—GABRA4—nicotine dependence	0.0098	0.0225	CbGpPWpGaD
Zolpidem—Throat irritation—Varenicline—nicotine dependence	0.00973	0.0172	CcSEcCtD
Zolpidem—Balance disorder—Varenicline—nicotine dependence	0.00898	0.0159	CcSEcCtD
Zolpidem—Suicide attempt—Varenicline—nicotine dependence	0.00865	0.0153	CcSEcCtD
Zolpidem—Parosmia—Varenicline—nicotine dependence	0.00757	0.0134	CcSEcCtD
Zolpidem—GABRB2—Ligand-gated ion channel transport—GABRA4—nicotine dependence	0.00751	0.0173	CbGpPWpGaD
Zolpidem—Menstrual disorder—Varenicline—nicotine dependence	0.0072	0.0127	CcSEcCtD
Zolpidem—Intestinal obstruction—Varenicline—nicotine dependence	0.0072	0.0127	CcSEcCtD
Zolpidem—GABRA3—Ligand-gated ion channel transport—GABRA4—nicotine dependence	0.00716	0.0165	CbGpPWpGaD
Zolpidem—GABRA2—Ligand-gated ion channel transport—GABRA4—nicotine dependence	0.00704	0.0162	CbGpPWpGaD
Zolpidem—GABRB3—Ligand-gated ion channel transport—GABRA4—nicotine dependence	0.00699	0.0161	CbGpPWpGaD
Zolpidem—Delusion—Varenicline—nicotine dependence	0.00694	0.0123	CcSEcCtD
Zolpidem—Thrombosis—Varenicline—nicotine dependence	0.00694	0.0123	CcSEcCtD
Zolpidem—GABRG2—Ligand-gated ion channel transport—GABRA4—nicotine dependence	0.00686	0.0158	CbGpPWpGaD
Zolpidem—Hyperlipidaemia—Varenicline—nicotine dependence	0.00681	0.012	CcSEcCtD
Zolpidem—Mania—Varenicline—nicotine dependence	0.00675	0.0119	CcSEcCtD
Zolpidem—Menorrhagia—Varenicline—nicotine dependence	0.00663	0.0117	CcSEcCtD
Zolpidem—CYP3A7—Xenobiotics—CYP2A7—nicotine dependence	0.00638	0.0147	CbGpPWpGaD
Zolpidem—GABRA1—Ligand-gated ion channel transport—GABRA4—nicotine dependence	0.006	0.0138	CbGpPWpGaD
Zolpidem—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00576	0.0132	CbGpPWpGaD
Zolpidem—Eye irritation—Varenicline—nicotine dependence	0.00575	0.0102	CcSEcCtD
Zolpidem—Disturbance in attention—Varenicline—nicotine dependence	0.00567	0.01	CcSEcCtD
Zolpidem—Aggression—Varenicline—nicotine dependence	0.00559	0.00988	CcSEcCtD
Zolpidem—Chest discomfort—Varenicline—nicotine dependence	0.00555	0.00982	CcSEcCtD
Zolpidem—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.00544	0.00962	CcSEcCtD
Zolpidem—Thinking abnormal—Varenicline—nicotine dependence	0.00536	0.00949	CcSEcCtD
Zolpidem—Nocturia—Varenicline—nicotine dependence	0.00529	0.00936	CcSEcCtD
Zolpidem—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00529	0.0122	CbGpPWpGaD
Zolpidem—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00525	0.0121	CbGpPWpGaD
Zolpidem—Dysarthria—Varenicline—nicotine dependence	0.00519	0.00918	CcSEcCtD
Zolpidem—Blood pressure increased—Varenicline—nicotine dependence	0.00491	0.00869	CcSEcCtD
Zolpidem—Pulmonary embolism—Varenicline—nicotine dependence	0.00491	0.00869	CcSEcCtD
Zolpidem—Abnormal dreams—Varenicline—nicotine dependence	0.00485	0.00858	CcSEcCtD
Zolpidem—Eructation—Varenicline—nicotine dependence	0.00482	0.00853	CcSEcCtD
Zolpidem—Salivary hypersecretion—Varenicline—nicotine dependence	0.00477	0.00844	CcSEcCtD
Zolpidem—Influenza like illness—Varenicline—nicotine dependence	0.00477	0.00844	CcSEcCtD
Zolpidem—Nightmare—Varenicline—nicotine dependence	0.00474	0.00839	CcSEcCtD
Zolpidem—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.00461	0.0106	CbGpPWpGaD
Zolpidem—Urine output increased—Varenicline—nicotine dependence	0.00444	0.00785	CcSEcCtD
Zolpidem—Mental disability—Varenicline—nicotine dependence	0.00426	0.00754	CcSEcCtD
Zolpidem—Euphoric mood—Varenicline—nicotine dependence	0.00422	0.00746	CcSEcCtD
Zolpidem—Lymphadenopathy—Varenicline—nicotine dependence	0.00418	0.00739	CcSEcCtD
Zolpidem—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00413	0.0095	CbGpPWpGaD
Zolpidem—Sleep disorder—Varenicline—nicotine dependence	0.00412	0.00728	CcSEcCtD
Zolpidem—Polyuria—Varenicline—nicotine dependence	0.00406	0.00718	CcSEcCtD
Zolpidem—Disorientation—Varenicline—nicotine dependence	0.00398	0.00705	CcSEcCtD
Zolpidem—GABRB2—GABA receptor activation—GABRA4—nicotine dependence	0.00398	0.00916	CbGpPWpGaD
Zolpidem—Eye pain—Varenicline—nicotine dependence	0.00395	0.00698	CcSEcCtD
Zolpidem—Injury—Varenicline—nicotine dependence	0.00388	0.00686	CcSEcCtD
Zolpidem—Renal failure acute—Varenicline—nicotine dependence	0.00386	0.00683	CcSEcCtD
Zolpidem—Libido decreased—Varenicline—nicotine dependence	0.00384	0.0068	CcSEcCtD
Zolpidem—Hot flush—Varenicline—nicotine dependence	0.00381	0.00674	CcSEcCtD
Zolpidem—GABRA3—GABA receptor activation—GABRA4—nicotine dependence	0.0038	0.00874	CbGpPWpGaD
Zolpidem—Amnesia—Varenicline—nicotine dependence	0.00379	0.00671	CcSEcCtD
Zolpidem—Increased appetite—Varenicline—nicotine dependence	0.00379	0.00671	CcSEcCtD
Zolpidem—Menopausal symptoms—Varenicline—nicotine dependence	0.00378	0.00668	CcSEcCtD
Zolpidem—Visual disturbance—Varenicline—nicotine dependence	0.00376	0.00665	CcSEcCtD
Zolpidem—Thirst—Varenicline—nicotine dependence	0.00375	0.00662	CcSEcCtD
Zolpidem—GABRA2—GABA receptor activation—GABRA4—nicotine dependence	0.00373	0.00859	CbGpPWpGaD
Zolpidem—GABRB3—GABA receptor activation—GABRA4—nicotine dependence	0.00371	0.00853	CbGpPWpGaD
Zolpidem—Arthritis—Varenicline—nicotine dependence	0.00367	0.00649	CcSEcCtD
Zolpidem—GABRG2—GABA receptor activation—GABRA4—nicotine dependence	0.00364	0.00838	CbGpPWpGaD
Zolpidem—Lethargy—Varenicline—nicotine dependence	0.00364	0.00643	CcSEcCtD
Zolpidem—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00357	0.00821	CbGpPWpGaD
Zolpidem—Osteoarthritis—Varenicline—nicotine dependence	0.00356	0.0063	CcSEcCtD
Zolpidem—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00354	0.00625	CcSEcCtD
Zolpidem—Affect lability—Varenicline—nicotine dependence	0.00351	0.00621	CcSEcCtD
Zolpidem—Migraine—Varenicline—nicotine dependence	0.00351	0.00621	CcSEcCtD
Zolpidem—Irritability—Varenicline—nicotine dependence	0.0034	0.00602	CcSEcCtD
Zolpidem—Urinary retention—Varenicline—nicotine dependence	0.00339	0.006	CcSEcCtD
Zolpidem—Mood swings—Varenicline—nicotine dependence	0.00338	0.00597	CcSEcCtD
Zolpidem—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00328	0.00755	CbGpPWpGaD
Zolpidem—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00325	0.00748	CbGpPWpGaD
Zolpidem—Breast disorder—Varenicline—nicotine dependence	0.00322	0.0057	CcSEcCtD
Zolpidem—Cramp muscle—Varenicline—nicotine dependence	0.00321	0.00568	CcSEcCtD
Zolpidem—Nasopharyngitis—Varenicline—nicotine dependence	0.00319	0.00564	CcSEcCtD
Zolpidem—GABRA1—GABA receptor activation—GABRA4—nicotine dependence	0.00318	0.00733	CbGpPWpGaD
Zolpidem—Gastritis—Varenicline—nicotine dependence	0.00315	0.00558	CcSEcCtD
Zolpidem—Dysphagia—Varenicline—nicotine dependence	0.00308	0.00545	CcSEcCtD
Zolpidem—Angina pectoris—Varenicline—nicotine dependence	0.003	0.00531	CcSEcCtD
Zolpidem—Bronchitis—Varenicline—nicotine dependence	0.00296	0.00524	CcSEcCtD
Zolpidem—Abdominal discomfort—Varenicline—nicotine dependence	0.00295	0.00522	CcSEcCtD
Zolpidem—Pollakiuria—Varenicline—nicotine dependence	0.00285	0.00503	CcSEcCtD
Zolpidem—Erectile dysfunction—Varenicline—nicotine dependence	0.00284	0.00502	CcSEcCtD
Zolpidem—Photosensitivity reaction—Varenicline—nicotine dependence	0.00281	0.00497	CcSEcCtD
Zolpidem—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00278	0.0064	CbGpPWpGaD
Zolpidem—Hyperglycaemia—Varenicline—nicotine dependence	0.00278	0.00492	CcSEcCtD
Zolpidem—Infestation—Varenicline—nicotine dependence	0.00275	0.00486	CcSEcCtD
Zolpidem—Infestation NOS—Varenicline—nicotine dependence	0.00275	0.00486	CcSEcCtD
Zolpidem—Depression—Varenicline—nicotine dependence	0.00274	0.00484	CcSEcCtD
Zolpidem—Acute coronary syndrome—Varenicline—nicotine dependence	0.00271	0.00479	CcSEcCtD
Zolpidem—Myocardial infarction—Varenicline—nicotine dependence	0.00269	0.00476	CcSEcCtD
Zolpidem—Stomatitis—Varenicline—nicotine dependence	0.00268	0.00474	CcSEcCtD
Zolpidem—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00267	0.00615	CbGpPWpGaD
Zolpidem—Conjunctivitis—Varenicline—nicotine dependence	0.00267	0.00472	CcSEcCtD
Zolpidem—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00265	0.0061	CbGpPWpGaD
Zolpidem—CYP3A7—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00262	0.00602	CbGpPWpGaD
Zolpidem—Epistaxis—Varenicline—nicotine dependence	0.00259	0.00458	CcSEcCtD
Zolpidem—Sinusitis—Varenicline—nicotine dependence	0.00258	0.00456	CcSEcCtD
Zolpidem—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00255	0.00586	CbGpPWpGaD
Zolpidem—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00253	0.00583	CbGpPWpGaD
Zolpidem—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.0025	0.00576	CbGpPWpGaD
Zolpidem—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00249	0.00572	CbGpPWpGaD
Zolpidem—Hypoaesthesia—Varenicline—nicotine dependence	0.00245	0.00434	CcSEcCtD
Zolpidem—Hallucination—Varenicline—nicotine dependence	0.00245	0.00434	CcSEcCtD
Zolpidem—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00244	0.00562	CbGpPWpGaD
Zolpidem—Urinary tract disorder—Varenicline—nicotine dependence	0.00244	0.00431	CcSEcCtD
Zolpidem—Connective tissue disorder—Varenicline—nicotine dependence	0.00242	0.00429	CcSEcCtD
Zolpidem—Urethral disorder—Varenicline—nicotine dependence	0.00242	0.00428	CcSEcCtD
Zolpidem—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00242	0.00556	CbGpPWpGaD
Zolpidem—Visual impairment—Varenicline—nicotine dependence	0.00238	0.0042	CcSEcCtD
Zolpidem—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00237	0.00546	CbGpPWpGaD
Zolpidem—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00236	0.00543	CbGpPWpGaD
Zolpidem—GABRB2—Orphan transporters—GABRA4—nicotine dependence	0.00232	0.00534	CbGpPWpGaD
Zolpidem—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00232	0.00533	CbGpPWpGaD
Zolpidem—Eye disorder—Varenicline—nicotine dependence	0.0023	0.00408	CcSEcCtD
Zolpidem—Tinnitus—Varenicline—nicotine dependence	0.0023	0.00407	CcSEcCtD
Zolpidem—Cardiac disorder—Varenicline—nicotine dependence	0.00229	0.00405	CcSEcCtD
Zolpidem—Mediastinal disorder—Varenicline—nicotine dependence	0.00222	0.00393	CcSEcCtD
Zolpidem—GABRA3—Orphan transporters—GABRA4—nicotine dependence	0.00222	0.0051	CbGpPWpGaD
Zolpidem—Chills—Varenicline—nicotine dependence	0.00221	0.00391	CcSEcCtD
Zolpidem—Arrhythmia—Varenicline—nicotine dependence	0.0022	0.0039	CcSEcCtD
Zolpidem—GABRA2—Orphan transporters—GABRA4—nicotine dependence	0.00218	0.00501	CbGpPWpGaD
Zolpidem—GABRB3—Orphan transporters—GABRA4—nicotine dependence	0.00216	0.00498	CbGpPWpGaD
Zolpidem—Mental disorder—Varenicline—nicotine dependence	0.00216	0.00382	CcSEcCtD
Zolpidem—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00215	0.00494	CbGpPWpGaD
Zolpidem—Erythema—Varenicline—nicotine dependence	0.00215	0.0038	CcSEcCtD
Zolpidem—Malnutrition—Varenicline—nicotine dependence	0.00215	0.0038	CcSEcCtD
Zolpidem—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00215	0.00494	CbGpPWpGaD
Zolpidem—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00214	0.00491	CbGpPWpGaD
Zolpidem—GABRG2—Orphan transporters—GABRA4—nicotine dependence	0.00212	0.00489	CbGpPWpGaD
Zolpidem—Flatulence—Varenicline—nicotine dependence	0.00212	0.00374	CcSEcCtD
Zolpidem—Dysgeusia—Varenicline—nicotine dependence	0.0021	0.00372	CcSEcCtD
Zolpidem—PTGS1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00208	0.00479	CbGpPWpGaD
Zolpidem—Back pain—Varenicline—nicotine dependence	0.00208	0.00367	CcSEcCtD
Zolpidem—Muscle spasms—Varenicline—nicotine dependence	0.00206	0.00365	CcSEcCtD
Zolpidem—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00202	0.00466	CbGpPWpGaD
Zolpidem—Vision blurred—Varenicline—nicotine dependence	0.00202	0.00358	CcSEcCtD
Zolpidem—Tremor—Varenicline—nicotine dependence	0.00201	0.00356	CcSEcCtD
Zolpidem—GABRB2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00201	0.00462	CbGpPWpGaD
Zolpidem—Ill-defined disorder—Varenicline—nicotine dependence	0.00199	0.00352	CcSEcCtD
Zolpidem—Anaemia—Varenicline—nicotine dependence	0.00198	0.00351	CcSEcCtD
Zolpidem—Agitation—Varenicline—nicotine dependence	0.00197	0.00349	CcSEcCtD
Zolpidem—Angioedema—Varenicline—nicotine dependence	0.00196	0.00347	CcSEcCtD
Zolpidem—Malaise—Varenicline—nicotine dependence	0.00194	0.00342	CcSEcCtD
Zolpidem—Vertigo—Varenicline—nicotine dependence	0.00193	0.00341	CcSEcCtD
Zolpidem—Syncope—Varenicline—nicotine dependence	0.00193	0.0034	CcSEcCtD
Zolpidem—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00192	0.00441	CbGpPWpGaD
Zolpidem—GABRA3—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00192	0.00441	CbGpPWpGaD
Zolpidem—GABRB2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.0019	0.00438	CbGpPWpGaD
Zolpidem—Palpitations—Varenicline—nicotine dependence	0.0019	0.00336	CcSEcCtD
Zolpidem—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00189	0.00435	CbGpPWpGaD
Zolpidem—Loss of consciousness—Varenicline—nicotine dependence	0.00189	0.00334	CcSEcCtD
Zolpidem—GABRA2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00188	0.00433	CbGpPWpGaD
Zolpidem—Cough—Varenicline—nicotine dependence	0.00187	0.00331	CcSEcCtD
Zolpidem—GABRB3—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00187	0.0043	CbGpPWpGaD
Zolpidem—GABRA1—Orphan transporters—GABRA4—nicotine dependence	0.00186	0.00427	CbGpPWpGaD
Zolpidem—Hypertension—Varenicline—nicotine dependence	0.00185	0.00328	CcSEcCtD
Zolpidem—GABRG2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00184	0.00423	CbGpPWpGaD
Zolpidem—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00183	0.00421	CbGpPWpGaD
Zolpidem—Arthralgia—Varenicline—nicotine dependence	0.00183	0.00323	CcSEcCtD
Zolpidem—Chest pain—Varenicline—nicotine dependence	0.00183	0.00323	CcSEcCtD
Zolpidem—Myalgia—Varenicline—nicotine dependence	0.00183	0.00323	CcSEcCtD
Zolpidem—Anxiety—Varenicline—nicotine dependence	0.00182	0.00322	CcSEcCtD
Zolpidem—GABRA3—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00182	0.00418	CbGpPWpGaD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00182	0.00321	CcSEcCtD
Zolpidem—Discomfort—Varenicline—nicotine dependence	0.00181	0.00319	CcSEcCtD
Zolpidem—Dry mouth—Varenicline—nicotine dependence	0.00179	0.00316	CcSEcCtD
Zolpidem—GABRA2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00178	0.00411	CbGpPWpGaD
Zolpidem—GABRB3—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00177	0.00408	CbGpPWpGaD
Zolpidem—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00176	0.00404	CbGpPWpGaD
Zolpidem—Oedema—Varenicline—nicotine dependence	0.00175	0.0031	CcSEcCtD
Zolpidem—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00175	0.00402	CbGpPWpGaD
Zolpidem—GABRG2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00174	0.00401	CbGpPWpGaD
Zolpidem—Infection—Varenicline—nicotine dependence	0.00174	0.00308	CcSEcCtD
Zolpidem—Shock—Varenicline—nicotine dependence	0.00172	0.00305	CcSEcCtD
Zolpidem—Nervous system disorder—Varenicline—nicotine dependence	0.00172	0.00304	CcSEcCtD
Zolpidem—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00172	0.00395	CbGpPWpGaD
Zolpidem—Tachycardia—Varenicline—nicotine dependence	0.00171	0.00302	CcSEcCtD
Zolpidem—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00171	0.00392	CbGpPWpGaD
Zolpidem—Skin disorder—Varenicline—nicotine dependence	0.0017	0.00301	CcSEcCtD
Zolpidem—Hyperhidrosis—Varenicline—nicotine dependence	0.00169	0.003	CcSEcCtD
Zolpidem—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00167	0.00385	CbGpPWpGaD
Zolpidem—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00167	0.00385	CbGpPWpGaD
Zolpidem—Anorexia—Varenicline—nicotine dependence	0.00167	0.00295	CcSEcCtD
Zolpidem—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00165	0.00379	CbGpPWpGaD
Zolpidem—Hypotension—Varenicline—nicotine dependence	0.00164	0.0029	CcSEcCtD
Zolpidem—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00163	0.00376	CbGpPWpGaD
Zolpidem—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00163	0.00375	CbGpPWpGaD
Zolpidem—GABRB2—Ion channel transport—GABRA4—nicotine dependence	0.00163	0.00375	CbGpPWpGaD
Zolpidem—GABRA1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00161	0.00369	CbGpPWpGaD
Zolpidem—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00161	0.00369	CbGpPWpGaD
Zolpidem—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.0016	0.00282	CcSEcCtD
Zolpidem—Insomnia—Varenicline—nicotine dependence	0.00158	0.0028	CcSEcCtD
Zolpidem—Dyspnoea—Varenicline—nicotine dependence	0.00156	0.00276	CcSEcCtD
Zolpidem—Somnolence—Varenicline—nicotine dependence	0.00156	0.00275	CcSEcCtD
Zolpidem—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00156	0.00358	CbGpPWpGaD
Zolpidem—GABRA3—Ion channel transport—GABRA4—nicotine dependence	0.00155	0.00358	CbGpPWpGaD
Zolpidem—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00155	0.00357	CbGpPWpGaD
Zolpidem—Dyspepsia—Varenicline—nicotine dependence	0.00154	0.00273	CcSEcCtD
Zolpidem—GABRB2—Neuronal System—CHRNB3—nicotine dependence	0.00154	0.00354	CbGpPWpGaD
Zolpidem—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00153	0.00352	CbGpPWpGaD
Zolpidem—GABRA2—Ion channel transport—GABRA4—nicotine dependence	0.00153	0.00351	CbGpPWpGaD
Zolpidem—Decreased appetite—Varenicline—nicotine dependence	0.00152	0.00269	CcSEcCtD
Zolpidem—GABRA1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00152	0.0035	CbGpPWpGaD
Zolpidem—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00152	0.0035	CbGpPWpGaD
Zolpidem—GABRB3—Ion channel transport—GABRA4—nicotine dependence	0.00152	0.00349	CbGpPWpGaD
Zolpidem—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00151	0.00268	CcSEcCtD
Zolpidem—Fatigue—Varenicline—nicotine dependence	0.00151	0.00267	CcSEcCtD
Zolpidem—Constipation—Varenicline—nicotine dependence	0.0015	0.00265	CcSEcCtD
Zolpidem—Pain—Varenicline—nicotine dependence	0.0015	0.00265	CcSEcCtD
Zolpidem—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00149	0.00343	CbGpPWpGaD
Zolpidem—GABRG2—Ion channel transport—GABRA4—nicotine dependence	0.00149	0.00343	CbGpPWpGaD
Zolpidem—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00148	0.00341	CbGpPWpGaD
Zolpidem—GABRA3—Neuronal System—CHRNB3—nicotine dependence	0.00147	0.00338	CbGpPWpGaD
Zolpidem—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00146	0.00337	CbGpPWpGaD
Zolpidem—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00146	0.00336	CbGpPWpGaD
Zolpidem—GABRB2—Neuronal System—CHRNA6—nicotine dependence	0.00146	0.00336	CbGpPWpGaD
Zolpidem—Feeling abnormal—Varenicline—nicotine dependence	0.00144	0.00255	CcSEcCtD
Zolpidem—GABRA2—Neuronal System—CHRNB3—nicotine dependence	0.00144	0.00332	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—CHRNB3—nicotine dependence	0.00143	0.0033	CbGpPWpGaD
Zolpidem—Gastrointestinal pain—Varenicline—nicotine dependence	0.00143	0.00253	CcSEcCtD
Zolpidem—GABRG2—Neuronal System—CHRNB3—nicotine dependence	0.00141	0.00324	CbGpPWpGaD
Zolpidem—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.0014	0.00323	CbGpPWpGaD
Zolpidem—Urticaria—Varenicline—nicotine dependence	0.00139	0.00246	CcSEcCtD
Zolpidem—GABRA3—Neuronal System—CHRNA6—nicotine dependence	0.00139	0.0032	CbGpPWpGaD
Zolpidem—Body temperature increased—Varenicline—nicotine dependence	0.00139	0.00245	CcSEcCtD
Zolpidem—Abdominal pain—Varenicline—nicotine dependence	0.00139	0.00245	CcSEcCtD
Zolpidem—GABRB2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00138	0.00317	CbGpPWpGaD
Zolpidem—GABRA2—Neuronal System—CHRNA6—nicotine dependence	0.00137	0.00315	CbGpPWpGaD
Zolpidem—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00136	0.00314	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—CHRNA6—nicotine dependence	0.00136	0.00313	CbGpPWpGaD
Zolpidem—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00135	0.00311	CbGpPWpGaD
Zolpidem—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00134	0.00309	CbGpPWpGaD
Zolpidem—GABRG2—Neuronal System—CHRNA6—nicotine dependence	0.00133	0.00307	CbGpPWpGaD
Zolpidem—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00133	0.00307	CbGpPWpGaD
Zolpidem—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00133	0.00306	CbGpPWpGaD
Zolpidem—GABRB2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00132	0.00304	CbGpPWpGaD
Zolpidem—GABRA3—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00131	0.00302	CbGpPWpGaD
Zolpidem—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.0013	0.003	CbGpPWpGaD
Zolpidem—GABRA1—Ion channel transport—GABRA4—nicotine dependence	0.0013	0.003	CbGpPWpGaD
Zolpidem—Hypersensitivity—Varenicline—nicotine dependence	0.00129	0.00228	CcSEcCtD
Zolpidem—GABRA2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00129	0.00297	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00129	0.00296	CbGpPWpGaD
Zolpidem—GABRB3—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00128	0.00295	CbGpPWpGaD
Zolpidem—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00127	0.00292	CbGpPWpGaD
Zolpidem—GABRG2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00126	0.0029	CbGpPWpGaD
Zolpidem—GABRA3—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00126	0.0029	CbGpPWpGaD
Zolpidem—Asthenia—Varenicline—nicotine dependence	0.00126	0.00222	CcSEcCtD
Zolpidem—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00125	0.00287	CbGpPWpGaD
Zolpidem—Pruritus—Varenicline—nicotine dependence	0.00124	0.00219	CcSEcCtD
Zolpidem—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00124	0.00285	CbGpPWpGaD
Zolpidem—GABRA2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00124	0.00285	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—CHRNB3—nicotine dependence	0.00123	0.00283	CbGpPWpGaD
Zolpidem—GABRB3—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00123	0.00283	CbGpPWpGaD
Zolpidem—GABRB2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00123	0.00282	CbGpPWpGaD
Zolpidem—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00122	0.0028	CbGpPWpGaD
Zolpidem—CYP3A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00121	0.00279	CbGpPWpGaD
Zolpidem—GABRG2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00121	0.00278	CbGpPWpGaD
Zolpidem—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0012	0.00276	CbGpPWpGaD
Zolpidem—Diarrhoea—Varenicline—nicotine dependence	0.0012	0.00212	CcSEcCtD
Zolpidem—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00117	0.00269	CbGpPWpGaD
Zolpidem—GABRA3—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00117	0.00269	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—CHRNA6—nicotine dependence	0.00117	0.00268	CbGpPWpGaD
Zolpidem—Dizziness—Varenicline—nicotine dependence	0.00116	0.00205	CcSEcCtD
Zolpidem—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00115	0.00266	CbGpPWpGaD
Zolpidem—GABRA2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00115	0.00265	CbGpPWpGaD
Zolpidem—GABRB3—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00114	0.00263	CbGpPWpGaD
Zolpidem—CYP3A7—Biological oxidations—CYP2A7—nicotine dependence	0.00114	0.00263	CbGpPWpGaD
Zolpidem—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00114	0.00262	CbGpPWpGaD
Zolpidem—CYP3A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00113	0.00259	CbGpPWpGaD
Zolpidem—GABRG2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00112	0.00258	CbGpPWpGaD
Zolpidem—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00112	0.00257	CbGpPWpGaD
Zolpidem—Vomiting—Varenicline—nicotine dependence	0.00111	0.00197	CcSEcCtD
Zolpidem—PTGS1—Biological oxidations—CYP2A7—nicotine dependence	0.00111	0.00255	CbGpPWpGaD
Zolpidem—Rash—Varenicline—nicotine dependence	0.0011	0.00195	CcSEcCtD
Zolpidem—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0011	0.00254	CbGpPWpGaD
Zolpidem—Dermatitis—Varenicline—nicotine dependence	0.0011	0.00195	CcSEcCtD
Zolpidem—GABRA1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.0011	0.00253	CbGpPWpGaD
Zolpidem—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.0011	0.00253	CbGpPWpGaD
Zolpidem—Headache—Varenicline—nicotine dependence	0.0011	0.00194	CcSEcCtD
Zolpidem—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00109	0.00252	CbGpPWpGaD
Zolpidem—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00109	0.00251	CbGpPWpGaD
Zolpidem—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00107	0.00246	CbGpPWpGaD
Zolpidem—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00106	0.00245	CbGpPWpGaD
Zolpidem—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00106	0.00245	CbGpPWpGaD
Zolpidem—GABRA1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00105	0.00243	CbGpPWpGaD
Zolpidem—GABRB2—Neuronal System—GABRA4—nicotine dependence	0.00105	0.00243	CbGpPWpGaD
Zolpidem—Nausea—Varenicline—nicotine dependence	0.00104	0.00184	CcSEcCtD
Zolpidem—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00101	0.00233	CbGpPWpGaD
Zolpidem—GABRB2—Neuronal System—CHRNB4—nicotine dependence	0.00101	0.00233	CbGpPWpGaD
Zolpidem—GABRA3—Neuronal System—GABRA4—nicotine dependence	0.00101	0.00231	CbGpPWpGaD
Zolpidem—GABRB2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.001	0.0023	CbGpPWpGaD
Zolpidem—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.000997	0.00229	CbGpPWpGaD
Zolpidem—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00099	0.00228	CbGpPWpGaD
Zolpidem—GABRA2—Neuronal System—GABRA4—nicotine dependence	0.000989	0.00227	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—GABRA4—nicotine dependence	0.000982	0.00226	CbGpPWpGaD
Zolpidem—GABRA1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.000981	0.00226	CbGpPWpGaD
Zolpidem—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.000973	0.00224	CbGpPWpGaD
Zolpidem—GABRG2—Neuronal System—GABRA4—nicotine dependence	0.000964	0.00222	CbGpPWpGaD
Zolpidem—GABRA3—Neuronal System—CHRNB4—nicotine dependence	0.000964	0.00222	CbGpPWpGaD
Zolpidem—GABRA3—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000954	0.0022	CbGpPWpGaD
Zolpidem—GABRA2—Neuronal System—CHRNB4—nicotine dependence	0.000948	0.00218	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—CHRNB4—nicotine dependence	0.000942	0.00217	CbGpPWpGaD
Zolpidem—GABRB2—Neuronal System—CHRNA5—nicotine dependence	0.00094	0.00216	CbGpPWpGaD
Zolpidem—GABRA2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000937	0.00216	CbGpPWpGaD
Zolpidem—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.000936	0.00215	CbGpPWpGaD
Zolpidem—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000936	0.00215	CbGpPWpGaD
Zolpidem—GABRB3—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000931	0.00214	CbGpPWpGaD
Zolpidem—GABRG2—Neuronal System—CHRNB4—nicotine dependence	0.000925	0.00213	CbGpPWpGaD
Zolpidem—GABRG2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000915	0.0021	CbGpPWpGaD
Zolpidem—GABRA3—Neuronal System—CHRNA5—nicotine dependence	0.000897	0.00206	CbGpPWpGaD
Zolpidem—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000891	0.00205	CbGpPWpGaD
Zolpidem—GABRA2—Neuronal System—CHRNA5—nicotine dependence	0.000881	0.00203	CbGpPWpGaD
Zolpidem—GABRB2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00088	0.00203	CbGpPWpGaD
Zolpidem—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000879	0.00202	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—CHRNA5—nicotine dependence	0.000875	0.00201	CbGpPWpGaD
Zolpidem—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000875	0.00201	CbGpPWpGaD
Zolpidem—GABRG2—Neuronal System—CHRNA5—nicotine dependence	0.00086	0.00198	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000859	0.00198	CbGpPWpGaD
Zolpidem—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00085	0.00196	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—GABRA4—nicotine dependence	0.000843	0.00194	CbGpPWpGaD
Zolpidem—GABRA3—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00084	0.00193	CbGpPWpGaD
Zolpidem—GABRA2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000825	0.0019	CbGpPWpGaD
Zolpidem—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.000825	0.0019	CbGpPWpGaD
Zolpidem—GABRB3—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00082	0.00189	CbGpPWpGaD
Zolpidem—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000814	0.00187	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—CHRNB4—nicotine dependence	0.000808	0.00186	CbGpPWpGaD
Zolpidem—GABRG2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000805	0.00185	CbGpPWpGaD
Zolpidem—GABRA1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000799	0.00184	CbGpPWpGaD
Zolpidem—GABRB2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000799	0.00184	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00078	0.00179	CbGpPWpGaD
Zolpidem—GABRB2—Neuronal System—CHRNA3—nicotine dependence	0.000766	0.00176	CbGpPWpGaD
Zolpidem—GABRA3—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000763	0.00175	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—CHRNA5—nicotine dependence	0.000751	0.00173	CbGpPWpGaD
Zolpidem—GABRA2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000749	0.00172	CbGpPWpGaD
Zolpidem—GABRB3—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000745	0.00171	CbGpPWpGaD
Zolpidem—GABRG2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000731	0.00168	CbGpPWpGaD
Zolpidem—GABRA3—Neuronal System—CHRNA3—nicotine dependence	0.000731	0.00168	CbGpPWpGaD
Zolpidem—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000722	0.00166	CbGpPWpGaD
Zolpidem—GABRA2—Neuronal System—CHRNA3—nicotine dependence	0.000718	0.00165	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—CHRNA3—nicotine dependence	0.000714	0.00164	CbGpPWpGaD
Zolpidem—GABRA1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000704	0.00162	CbGpPWpGaD
Zolpidem—GABRG2—Neuronal System—CHRNA3—nicotine dependence	0.000701	0.00161	CbGpPWpGaD
Zolpidem—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000677	0.00156	CbGpPWpGaD
Zolpidem—GABRB2—Neuronal System—CHRNB2—nicotine dependence	0.000675	0.00155	CbGpPWpGaD
Zolpidem—GABRA3—Neuronal System—CHRNB2—nicotine dependence	0.000643	0.00148	CbGpPWpGaD
Zolpidem—GABRA1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000639	0.00147	CbGpPWpGaD
Zolpidem—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.000638	0.00147	CbGpPWpGaD
Zolpidem—GABRA2—Neuronal System—CHRNB2—nicotine dependence	0.000632	0.00146	CbGpPWpGaD
Zolpidem—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000629	0.00145	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—CHRNB2—nicotine dependence	0.000628	0.00145	CbGpPWpGaD
Zolpidem—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000622	0.00143	CbGpPWpGaD
Zolpidem—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000617	0.00142	CbGpPWpGaD
Zolpidem—GABRG2—Neuronal System—CHRNB2—nicotine dependence	0.000617	0.00142	CbGpPWpGaD
Zolpidem—GABRB2—Neuronal System—CHRNA4—nicotine dependence	0.000613	0.00141	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—CHRNA3—nicotine dependence	0.000613	0.00141	CbGpPWpGaD
Zolpidem—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000587	0.00135	CbGpPWpGaD
Zolpidem—GABRA3—Neuronal System—CHRNA4—nicotine dependence	0.000584	0.00134	CbGpPWpGaD
Zolpidem—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000582	0.00134	CbGpPWpGaD
Zolpidem—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000579	0.00133	CbGpPWpGaD
Zolpidem—GABRA2—Neuronal System—CHRNA4—nicotine dependence	0.000574	0.00132	CbGpPWpGaD
Zolpidem—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000574	0.00132	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—CHRNA4—nicotine dependence	0.00057	0.00131	CbGpPWpGaD
Zolpidem—GABRB2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000567	0.0013	CbGpPWpGaD
Zolpidem—GABRG2—Neuronal System—CHRNA4—nicotine dependence	0.00056	0.00129	CbGpPWpGaD
Zolpidem—GABRA3—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000541	0.00124	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—CHRNB2—nicotine dependence	0.000539	0.00124	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000532	0.00122	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000528	0.00122	CbGpPWpGaD
Zolpidem—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000527	0.00121	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000519	0.00119	CbGpPWpGaD
Zolpidem—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000497	0.00114	CbGpPWpGaD
Zolpidem—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00049	0.00113	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—CHRNA4—nicotine dependence	0.00049	0.00113	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000453	0.00104	CbGpPWpGaD
Zolpidem—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000407	0.000936	CbGpPWpGaD
Zolpidem—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000384	0.000883	CbGpPWpGaD
Zolpidem—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000378	0.000871	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—CYP2A7—nicotine dependence	0.000195	0.000449	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—CYP2A7—nicotine dependence	0.000189	0.000435	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000141	0.000325	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000109	0.000251	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.0001	0.000231	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CYP2A7—nicotine dependence	9.95e-05	0.000229	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CYP2A7—nicotine dependence	8.5e-05	0.000196	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CYP2A7—nicotine dependence	6.56e-05	0.000151	CbGpPWpGaD
